MDTH » Topics » Overview

These excerpts taken from the MDTH 10-K filed Dec 15, 2008.
Overview
 
We were incorporated in Delaware in 2001 as a healthcare provider and are focused primarily on providing high acuity services, including the diagnosis and treatment of cardiovascular disease. We own and operate hospitals in partnership with physicians whom we believe have established reputations for clinical excellence. We opened our first hospital in 1996 and currently have ownership interests in and operate nine hospitals, including seven in which we own a majority interest. Each of our majority-owned hospitals is a freestanding, licensed general acute care hospital that provides a wide range of health services with a focus on cardiovascular care. Each of our hospitals has a 24-hour emergency room staffed by emergency department physicians. The hospitals in which we have ownership interests have a total of 676 licensed beds and are located in predominantly high growth markets in seven states: Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. We are currently in the process of developing a new acute care hospital in Kingman, Arizona which we expect to open in late 2009 or early 2010. This hospital is designed to accommodate a total of 106 licensed beds and will initially open with 70 licensed beds. We expanded our patient beds by 28 licensed beds at Arkansas Heart Hospital earlier this year and just completed a 60 bed addition at TexSAn Heart Hospital (TexSAn) in August 2008. We are expanding our licensed beds by 80 at Louisiana Medical Center and Heart Hospital with remaining capacity for an additional 40 beds at that hospital. We expect this 79 licensed bed expansion to open in 2009. We also have plans to expand our Bakersfield Heart Hospital by 72 inpatient beds and 16 emergency department beds that will diversify the services offered by the hospital. The expansion is subject to the approval of California’s Office of Statewide Health Planning and Development (OSHPD).
 
In addition to our hospitals, we currently own and/or manage 20 cardiac diagnostic and therapeutic facilities. Eight of these facilities are located at hospitals operated by other parties. These facilities offer invasive diagnostic and, in some cases, therapeutic procedures. The remaining seven facilities are not located at hospitals and offer only diagnostic procedures. We refer to our diagnostics division as “MedCath Partners.” For financial data and other information of this and other segments of our business see Note 19 to our consolidated financial statements in Item 8 of this report for financial information by segment.
 
We believe our facilities provide superior clinical outcomes, which, together with our ability to provide management capabilities and capital resources, positions us to expand upon our relationships with physicians and community hospitals to increase our presence in existing and new markets. Specifically, we plan to increase our revenue and income from operations through a combination of:
 
  •  improved operating performance at our existing facilities;
 
  •  increased capacity and expanded scope of services provided at certain of our existing hospitals;
 
  •  the development of new relationships with physicians in certain of our existing markets;
 
  •  the establishment of new ventures with physicians in new markets; and
 
  •  selective evaluation of acquisitions of specialty and general acute care facilities.
 
We are subject to the informational requirements of the Securities Exchange Act of 1934 (the Exchange Act) and therefore, we file reports, proxy statements and other information with the Securities and Exchange Commission (SEC). Such reports may be read and copied at the Public Reference Room of the SEC at 100 F Street NE, Washington, D.C. 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at (800) SEC-0330. In addition, the SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements and other information regarding issuers that file electronically.
 
We maintain an Internet website at www.medcath.com that investors and interested parties can access and obtain copies, free-of-charge, of all reports, proxy and information statements and other information that the Company submits to the SEC as soon as reasonably practicable after we electronically submit such material to the SEC. This information includes copies of our proxy statements, annual reports on Form 10-K, quarterly reports on


1


Table of Contents

Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act.
 
Investors and interested parties can also submit electronic requests for information directly to the Company at the following e-mail address: ir@medcath.com. Alternatively, communications can be mailed to the attention of “Investor Relations” at the Company’s executive offices.
 
Information on our website is not incorporated into this Form 10-K or our other securities filings and is not a part of them.
 
Overview


 



We were incorporated in Delaware in 2001 as a healthcare
provider and are focused primarily on providing high acuity
services, including the diagnosis and treatment of
cardiovascular disease. We own and operate hospitals in
partnership with physicians whom we believe have established
reputations for clinical excellence. We opened our first
hospital in 1996 and currently have ownership interests in and
operate nine hospitals, including seven in which we own a
majority interest. Each of our majority-owned hospitals is a
freestanding, licensed general acute care hospital that provides
a wide range of health services with a focus on cardiovascular
care. Each of our hospitals has a
24-hour
emergency room staffed by emergency department physicians. The
hospitals in which we have ownership interests have a total of
676 licensed beds and are located in predominantly high growth
markets in seven states: Arizona, Arkansas, California,
Louisiana, New Mexico, South Dakota, and Texas. We are currently
in the process of developing a new acute care hospital in
Kingman, Arizona which we expect to open in late 2009 or early
2010. This hospital is designed to accommodate a total of 106
licensed beds and will initially open with 70 licensed beds. We
expanded our patient beds by 28 licensed beds at Arkansas Heart
Hospital earlier this year and just completed a 60 bed
addition at TexSAn Heart Hospital (TexSAn) in August 2008. We
are expanding our licensed beds by 80 at Louisiana Medical
Center and Heart Hospital with remaining capacity for an
additional 40 beds at that hospital. We expect this 79 licensed
bed expansion to open in 2009. We also have plans to expand our
Bakersfield Heart Hospital by 72 inpatient beds and 16 emergency
department beds that will diversify the services offered by the
hospital. The expansion is subject to the approval of
California’s Office of Statewide Health Planning and
Development (OSHPD).


 



In addition to our hospitals, we currently own
and/or
manage 20 cardiac diagnostic and therapeutic facilities. Eight
of these facilities are located at hospitals operated by other
parties. These facilities offer invasive diagnostic and, in some
cases, therapeutic procedures. The remaining seven facilities
are not located at hospitals and offer only diagnostic
procedures. We refer to our diagnostics division as
“MedCath Partners.” For financial data and other
information of this and other segments of our business see
Note 19 to our consolidated financial statements in
Item 8 of this report for financial information by segment.


 



We believe our facilities provide superior clinical outcomes,
which, together with our ability to provide management
capabilities and capital resources, positions us to expand upon
our relationships with physicians and community hospitals to
increase our presence in existing and new markets. Specifically,
we plan to increase our revenue and income from operations
through a combination of:


 
























































  • 

improved operating performance at our existing facilities;
 
  • 

increased capacity and expanded scope of services provided at
certain of our existing hospitals;
 
  • 

the development of new relationships with physicians in certain
of our existing markets;
 
  • 

the establishment of new ventures with physicians in new
markets; and
 
  • 

selective evaluation of acquisitions of specialty and general
acute care facilities.


 



We are subject to the informational requirements of the
Securities Exchange Act of 1934 (the Exchange Act) and
therefore, we file reports, proxy statements and other
information with the Securities and Exchange Commission (SEC).
Such reports may be read and copied at the Public Reference Room
of the SEC at 100 F Street NE, Washington, D.C.
20549. Information on the operation of the Public Reference Room
may be obtained by calling the SEC at (800) SEC-0330. In
addition, the SEC maintains an Internet site (www.sec.gov) that
contains reports, proxy and information statements and other
information regarding issuers that file electronically.


 



We maintain an Internet website at www.medcath.com that
investors and interested parties can access and obtain copies,
free-of-charge, of all reports, proxy and information statements
and other information that the Company submits to the SEC as
soon as reasonably practicable after we electronically submit
such material to the SEC. This information includes copies of
our proxy statements, annual reports on
Form 10-K,
quarterly reports on





1





Table of Contents






Form 10-Q,
current reports on
Form 8-K,
and amendments to those reports filed or furnished pursuant to
Section 13(a) or 15(d) of the Exchange Act.


 



Investors and interested parties can also submit electronic
requests for information directly to the Company at the
following
e-mail
address: ir@medcath.com. Alternatively, communications
can be mailed to the attention of “Investor Relations”
at the Company’s executive offices.


 



Information on our website is not incorporated into this
Form 10-K
or our other securities filings and is not a part of them.


 




This excerpt taken from the MDTH 10-K filed Dec 14, 2007.
Overview
 
We were incorporated in Delaware in 2001 as a healthcare provider and are focused primarily on providing high acuity services, including the diagnosis and treatment of cardiovascular disease. We own and operate hospitals in partnership with physicians whom we believe have established reputations for clinical excellence. We opened our first hospital in 1996 and currently have ownership interests in and operate 11 hospitals, including nine in which we own a majority interest. Each of our majority-owned hospitals is a freestanding, licensed general acute care hospital that provides a wide range of health services with a focus on cardiovascular care. Each of our hospitals has a 24-hour emergency room staffed by emergency department physicians. The hospitals in which we have ownership interests have a total of 667 licensed beds and are located in predominantly high growth markets in eight states: Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. We are currently developing a new acute care hospital in Kingman, Arizona which we expect to open in Fall 2009. This hospital is designed to accommodate a total of 106 licensed beds and will initially open with 70 licensed beds.
 
In addition to our hospitals, we currently own and/or manage 25 cardiac diagnostic and therapeutic facilities. Nine of these facilities are located at hospitals operated by other parties and one of these facilities is located at a hospital in which we own a minority interest. These facilities offer invasive diagnostic and, in some cases, therapeutic procedures. The remaining 11 facilities are not located at hospitals and offer only diagnostic procedures. Effective January 1, 2007, we renamed our diagnostics division “MedCath Partners.” See Note 19 to our consolidated financial statements in Item 8 of this report for financial information by segment.
 
We believe our facilities provide superior clinical outcomes, which, together with our ability to provide management capabilities and capital resources, positions us to expand upon our relationships with physicians and community hospitals to increase our presence in existing and new markets. Specifically, we plan to increase our revenue and income from operations through a combination of:
 
  •  improved operating performance at our existing facilities;
 
  •  increased capacity and expanded scope of services provided at certain of our existing hospitals;
 
  •  the development of new relationships with physicians in certain of our existing markets;
 
  •  the establishment of new ventures with physicians in new markets; and
 
  •  selective evaluation of acquisitions of specialty and general acute care facilities.
 
We are subject to the informational requirements of the Securities Exchange Act of 1934 (the Exchange Act) and therefore, we file periodic reports, proxy statements and other information with the Securities and Exchange Commission (SEC). Such reports may be read and copied at the Public Reference Room of the SEC at 100 F Street NE, Washington, D.C. 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at (800) SEC-0330. In addition, the SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements and other information regarding issuers that file electronically.
 
We maintain an Internet website at www.medcath.com that investors and interested parties can access, free-of-charge, to obtain copies of all reports, proxy and information statements and other information that the Company submits to the SEC as soon as reasonably practicable after we electronically submit such material to the SEC. This information includes copies of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act.
 
Investors and interested parties can also submit electronic requests for information directly to the Company at the following e-mail address: ir@medcath.com. Alternatively, communications can be mailed to the attention of “Investor Relations” at the Company’s executive offices.
 
Information on our website is not incorporated into this Form 10-K or our other securities filings and is not a part of them.


1


Table of Contents

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki